跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DESVENLAFAXINE GH XR desvenlafaxine (as benzoate) 100 mg extended release tablets blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
DESVENLAFAXINE GH XR desvenlafaxine (as benzoate) 100 mg extended release tablets blister pack
Approved
STANDARD
DESVENLAFAXINE GH XR desvenlafaxine (as benzoate) 100 mg extended release tablets blister pack
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
137c82bd729964c2
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
137c82bd729964c2
Product Name
DESVENLAFAXINE GH XR desvenlafaxine (as benzoate) 100 mg extended release tablets blister pack
Artg Id
227806
Artg Name
DESVENLAFAXINE GH XR desvenlafaxine (as benzoate) 100 mg extended release tablets blister pack
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2014-11-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/14257eb6c5f0e43a1eed6d12545cb051.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/9bc5aae11e87761b57b4d5bcc76c49a1.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
137c82bd729964c2
Type
Standard
Back to TGA Approvals